This study is accepting new patients by invitation only

COVID-19 in Patients With Chronic Liver Diseases

a study on COVID-19 Liver Disease

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Fresno, California and other locations
Dates
study started
estimated completion

Description

Summary

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Keywords

COVID-19 Chronic Liver Disease Liver Diseases Prospective Chart Review

Eligibility

You can join if…

Open to people ages 18 years and up

  • Confirmed diagnosis of COVID-19
  • Personal history of either
  • Chronic hepatitis C
  • Chronic hepatitis B
  • Alcoholic liver disease
  • Non alcoholic liver disease
  • Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis
  • Cryptogenic cirrhosis
  • Hepatocellular carcinoma

You CAN'T join if...

  • Non-COVID-19 patient

Locations

  • UCSF Fresno
    Fresno California 93701 United States
  • Stanford University
    Stanford California 94305 United States

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Stanford University
ID
NCT04439084
Study Type
Observational
Last Updated